Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
38874075
DOI
10.1210/clinem/dgae354
PII: 7693359
Knihovny.cz E-zdroje
- Klíčová slova
- NIFTP, nuclear score, papillary carcinoma, pathology, thyroid tumors,
- MeSH
- buněčné jádro patologie MeSH
- folikulární adenokarcinom * patologie epidemiologie diagnóza MeSH
- lékařská praxe - způsoby provádění statistika a číselné údaje MeSH
- lidé MeSH
- nádory štítné žlázy * epidemiologie patologie diagnóza MeSH
- papilární karcinom štítné žlázy epidemiologie patologie diagnóza MeSH
- papilární karcinom patologie epidemiologie diagnóza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Asie epidemiologie MeSH
- Evropa epidemiologie MeSH
- Oceánie epidemiologie MeSH
- Severní Amerika epidemiologie MeSH
CONTEXT: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) was introduced as a new entity replacing the diagnosis of noninvasive encapsulated follicular variant of papillary thyroid carcinoma (PTC). Significant variability in the incidence of NIFTP diagnosed in different world regions has been reported. OBJECTIVE: To investigate the rate of adoption of NIFTP, change in practice patterns, and uniformity in applying diagnostic criteria among pathologists practicing in different regions. METHODS: Two surveys distributed to pathologists of the International Endocrine Pathology Discussion Group with multiple-choice questions on NIFTP adoption into pathology practice and whole slide images of 5 tumors to collect information on nuclear score and diagnosis. Forty-eight endocrine pathologists, including 24 from North America, 8 from Europe, and 16 from Asia/Oceania completed the first survey and 38 the second survey. RESULTS: A 94% adoption rate of NIFTP by the pathologists was found. Yet, the frequency of rendering NIFTP diagnosis was significantly higher in North America than in other regions (P = .009). While the highest concordance was found in diagnosing lesions with mildly or well-developed PTC-like nuclei, there was significant variability in nuclear scoring and diagnosing NIFTP for tumors with moderate nuclear changes (nuclear score 2) (case 2, P < .05). Pathologists practicing in North America and Europe showed a tendency for lower thresholds for PTC-like nuclei and NIFTP than those practicing in Asia/Oceania. CONCLUSION: Despite a high adoption rate of NIFTP across geographic regions, NIFTP is diagnosed more often by pathologists in North America. Significant differences remain in diagnosing intermediate PTC-like nuclei and respectively NIFTP, with more conservative nuclear scoring in Asia/Oceania, which may explain the geographic differences in NIFTP incidence.
Department of Medical Biology and Pathology Institute Gustave Roussy Villejuif 94800 France
Department of Oncology Belarus Medical State University Minsk 220116 Belarus
Department of Pathology All India Institute of Medical Sciences New Delhi 110029 India
Department of Pathology and Laboratory Medicine Mayo Clinic Arizona Scottsdale AZ 85259 USA
Department of Pathology and Laboratory Medicine Taipei Veterans General Hospital Taipei 11217 Taiwan
Department of Pathology Chulalongkorn University Bangkok 10330 Thailand
Department of Pathology Faculty of Medicine Gaziantep University Gaziantep 27310 Turkey
Department of Pathology Kameda Medical Center Kamogawa Chiba 296 8602 Japan
Department of Pathology King George's Medical University Lucknow 226003 India
Department of Pathology Massachusetts General Hospital Boston MA 02114 USA
Department of Pathology McGill University Montreal Quebec H3T 1E2 Canada
Department of Pathology Medical Faculty of Istanbul Istanbul University 34093 Istanbul Turkey
Department of Pathology Shanghai Sixth People's Hospital Shanghai 201306 China
Department of Pathology The University of Chicago Chicago IL 60637 USA
Department of Pathology University of Calgary Calgary Alberta T2N 2T9 Canada
Department of Pathology University of California San Francisco San Francisco CA 94143 USA
Department of Pathology University of Iowa Hospitals and Clinics Iowa City IA 52242 USA
Department of Pathology University of Pittsburgh Medical Center Pittsburgh PA 15213 USA
Department of Pathology Yale School of Medicine New Haven CT 06510 USA
Citace poskytuje Crossref.org